A carregar...

Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

A pilot trial of enzyme replacement with splenic and plasma alpha-galactosidase A (alpha-D-galactosidase; alpha-D-galactoside galactohydrolase, EC 3.2.1.22) isozymes was undertaken in two brothers with Fabry disease, an X-linked glycosphingolipid storage disease. Six unentrapped doses (2000 units/kg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Desnick, R J, Dean, K J, Grabowski, G, Bishop, D F, Sweeley, C C
Formato: Artigo
Idioma:Inglês
Publicado em: 1979
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC413135/
https://ncbi.nlm.nih.gov/pubmed/228284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!